MRVI · Maravai LifeSciences Holdings Inc
United States · RS rating 90 · As of 2026-11-03
| Price | 7.45 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 31 / 87 / 96 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 72 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -33.3% |
| Sales growth Q/Q | +19.8% |
| Distance from 52-week high | +17.2% |
| Market cap (USD) | $1.3B |